Zhuhai Rundu Pharmaceutical Co.,Ltd. is approved by USFDA, WHO, NMPA, MFDS, PMDA etc.authorities, specialized in the pharmaceutical APIs and intermediates, takes advantage of the production in SARTAN antihypertensive bulk, with the best quality and the most massive production in the domestic market. Our main products include not only Valsartan,Irbesartan Candesartan Cilexetil,Olmesartan Medoxomil, Sacubitril / Valsartan and their related intermediates, but also Piperaquine Phosphate and Voriconazole etc.
more >
Year of Establishment:
1997
Total Assets(USD):
500,000 to 99,999,999
Total Number of Staff:
more than 1000
Main Competitive Advantages:
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Own Brand
Annual Turnover(USD):
500,000 to 99,999,999
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Asia,Middle East,Africa
Other Competitive Advantages:
Patents and Copyrights: